BioStable Science & Engineering Announces CE Mark Approval for the HAART 300 Aortic Annuloplasty Device

BioStable Science & Engineering, Inc. announced today the company has received CE Mark approval for the HAART 300 Aortic Annuloplasty Device, the first commercially available internal aortic annuloplasty ring for aortic valve repair. The company expects to begin a limited commercial launch of the product in select European heart centers in the second quarter of 2016. (Read More)